Home > News > featured news > SpinaFX Medical to Exhibit at Society of Interventional Radiology Annual Scientific Meeting

Future of Healthcare

SpinaFX Medical to Exhibit at Society of Interventional Radiology Annual Scientific Meeting

Spinafx medical inc | June 13, 2022

SpinaFX Medical

Minimally invasive image-guided therapy company, SpinaFX Medical Inc. announced it will exhibit at the Society of Interventional Radiology (SIR) 2022 Annual Scientific Meeting in Boston, MA,��June 11-16, at booth 414. Dr. Alexis Kelekis, medical advisor to SpinaFX, will present the results of a research study on which he was the lead author, recently published in The Spine Journal, on the effectiveness of intradiscal oxygen-ozone treatment compared to microdiscectomy for contained lumbar disc herniation with radiculopathy. This study has been recognized by SIR as one of the 2022 Abstracts of the Year.

"We are excited to meet with some of the world's leading interventional radiologists to discuss innovations in minimally invasive, image-guided care and share our recent progress and momentum at SpinaFX. We look forward to Dr. Kelekis' presentation and celebrate the study's findings, which have the potential to benefit both patients and providers by addressing a significant gap in the continuum of care for the millions suffering from back pain."

Jeff Cambra, SpinaFX CEO

"I am thrilled that Dr. Kelekis will share the findings of our skilled research team at SIR's Annual Scientific Meeting," said Dr. Kieran Murphy, SpinaFX Chief Medical Officer and co-author of the recognized study. "The technology used in this randomized control trial holds great promise for patients struggling with contained herniated lumbar disc pain and it is an honor to have this research recognized by such a prestigious and well-respected organization."

Dr. Alexis Kelekis will present the results of his study on Wednesday, June 15, at 10:40 a.m. during Closing Plenary.

As an exhibitor during the meeting on June 11-16, SpinaFX will offer attendees the opportunity to discuss the study results and their implications with Drs. Kelekis and Murphy, learn more about SpinaFX and its goal to help develop minimally invasive, image-guided treatment options, and provide input on developing technology with the potential to redefine the treatment of contained herniated discs. Visit SIR's website to learn more about the Annual Scientific Meeting.

About SpinaFX

Headquartered in Ontario, Canada, SpinaFX is a treatment solution and technology company bringing innovative, minimally invasive image-guided treatments to patients with back pain due to contained herniated discs.

Spotlight

GE HealthCare LifeCycle Solutions Circular Economy

The video highlights the programs and processes GE HealthCare uses in creating a circular economy for our medical imaging equipment.  We work globally to reuse, recycle, repair and refurbish our GE HealthCare systems and parts, helping to create a more sustainable future.

More featured news

Spotlight

GE HealthCare LifeCycle Solutions Circular Economy

The video highlights the programs and processes GE HealthCare uses in creating a circular economy for our medical imaging equipment.  We work globally to reuse, recycle, repair and refurbish our GE HealthCare systems and parts, helping to create a more sustainable future.

Related News

Health Technology, Healthcare Analytics

AmeriPro Health expands to Kentucky and Indiana with acquisition of AMR's operations

prnewswire | August 07, 2023

AmeriPro Health, a leading provider of patient logistics and last-mile healthcare delivery services, has acquired American Medical Response, Inc.'s (AMR) operations in Lexington and Louisville, Kentucky, and New Albany, Indiana. As a result of the acquisition, AmeriPro Health now provides these three markets, which include UofL Health, University of Louisville Athletics and UK HealthCare, with its customizable suite of patient-centric 911, inter-facility medical transportation, critical care and advanced life support (ALS) services. "We're thrilled to bring AmeriPro's innovative last-mile services to Lexington, Louisville and New Albany," says Suhas Uppalapati, CEO of AmeriPro Health. "AmeriPro is steadfast in our commitment to revolutionize patient logistics. We aim to provide members of these communities - and blue-chip institutional partners such as UK HealthCare and UofL Health, along with other local hospitals, health plans and employers - with unmatched patient health services." This news follows AmeriPro's 2022 acquisition of CareMed, an ambulance service provider in Mississippi and Tennessee, and Ambulance Service, Inc., a longstanding Jacksonville, Florida-based EMS provider, in 2019. Established in 2018 with 10 ambulances in the Metro Atlanta area, AmeriPro Health has rapidly grown to 800+ employees with operations across six states. About AmeriPro Health AmeriPro Health encompasses a diverse range of healthcare companies devoted to optimizing patient logistics and last-mile healthcare delivery. Our extensive portfolio comprises emergency and critical care services, non-emergency medical transportation, patient coordination and personalized home-based care solutions, providing a seamless patient care journey. By covering the complete spectrum of patient care, we ensure enhanced patient outcomes, more efficient healthcare processes and timely, location-appropriate access to care. At AmeriPro Health, we provide an adaptable suite of patient-centric, value-driven services, tailored to meet the needs of communities, health systems, health plans and employers. As a pioneer in last-mile healthcare, our strength lies in our capacity to anticipate future needs, swiftly adapt and deliver on the evolving demands of our clients.

Read More

Digital Healthcare, Healthcare Analytics

Equum Medical Launches the Lighthouse Series™: Inspiring Success Stories in Telehealth and Healthcare Transformation

PRNewswire | July 24, 2023

Evidence is mounting from the experiences of hospitals large and small, urban and rural that telehealth is having a positive effect on staffing, patient safety, clinical services and hospital revenue, Equum Medical reports. The company, a leading provider of innovative telehealth services, has released the Equum Medical Lighthouse Series™. These customer success stories showcase the transformative power of telehealth in addressing key challenges faced by health systems and hospitals worldwide. The Series is intended to highlight real-world examples of how a complete acute care telehealth service using remote physicians, nurses and monitoring technologists supplements current hospital staff, provides specialist expertise and quickly moves patients to the most appropriate sites for care. In today's rapidly evolving healthcare landscape, health systems and hospitals are constantly seeking innovative solutions to enhance efficiency, reduce costs and improve patient outcomes. The Equum Medical Lighthouse Series brings to the forefront some of the most pressing challenges faced by healthcare providers, including ED capacity, ICU mortality and length of stay, physician and nurse burnout, and rural hospital specialist access. Telehealth offers a promising solution by increasing access to care in underserved areas, alleviating the shortage of clinicians and reducing costs to make healthcare more accessible and affordable. Dr. Scurlock, CEO and Founder of Equum Medical, emphasized the importance of sharing these success stories: "We are thrilled to launch the Equum Medical Lighthouse Series. By showcasing real-world examples of how telehealth has successfully addressed critical challenges, we aim to encourage broader adoption of telehealth and the dissemination of information on successful strategies." The series aims to provide healthcare leaders with actionable insights and evidence-based strategies to navigate their own telehealth implementations by demonstrating the tangible benefits that can be achieved by embracing telehealth and leveraging its potential to drive positive change in healthcare delivery. Healthcare providers, administrators and industry professionals can gain a valuable resource for understanding the diverse applications of telehealth and the significant impact it can have on healthcare delivery, patient outcomes and the overall well-being of both patients and providers. "We are going to continue to grow the Lighthouse Series as we get additional results from our engagements," said Karsten Russell-Wood, MBA, MPH, Equum's Chief Marketing Officer. "We want this to be a resource for innovators and evidence of what our model of care can do to ease the pressure on hospitals and health systems in this time of profound change for our industry." Equum Medical is an active member of the American Telemedicine Association and the National Rural Health Association, through which participating hospital systems can access thought leadership and engage with Equum Medical executives to expand telehealth understanding and applications. About Equum Equum Medical is a nationally recognized, tech-enabled clinical services company that provides the people and processes that ensure investments in telehealth technology succeed in transforming inpatient care. Equum's clinical services platform focuses on the acute care population spanning ED, ICU, nursing and sitter solutions.

Read More

Health Technology, Healthcare Analytics

Capital Rx Launches Rx Reverse in Partnership with Virta Health to Combat Type 2 Diabetes and Obesity

PRNewswire | July 18, 2023

Capital Rx, the health technology company changing the way prescription drugs are priced and patients are cared for, and type 2 diabetes (T2D) reversal leader Virta Health have partnered to introduce Rx Reverse. Available to all of Capital Rx's customers, Rx Reverse is a high-touch, provider-led, integrated clinical program designed to help members reverse T2D and fight obesity without costly medications. The problem is clear: 37+ million Americans have been diagnosed with diabetes, and over 90% of them have T2D (including one-third of the population over 65 years old).1 At the same time, the prevalence of obesity is over 40% of the U.S. population2 and is expected to reach nearly 50% by 2030.3 During a June 15, 2023 webinar, Rethinking Obesity Strategies: The Rise of GLP-1 Drugs and Lifestyle Programs for Weight Loss, Virta revealed new survey data highlighting that diabetes and obesity are the #1 and #2 concerns of health plan leaders in 2023 because of rising costs and downstream health impact. The launch of Rx Reverse comes as demand for GLP-1 drugs approved for diabetes and weight loss is rising rapidly, and employers and health plan leaders focus on managing the cost of diabetes and obesity. Rx Reverse combines Capital Rx's tech-enabled pharmacy benefit management (PBM) service model, powered by JUDI®, and Virta's solution – personalized nutrition therapy, physician-led deprescription, remote monitoring, and one-on-one coaching – to help health plans reduce costs and improve members' health. "Leveraging JUDI, our proprietary next-generation claim adjudication platform for Medicare, Medicaid, and commercial plans, we have the ability to seamlessly connect with vendors like Virta, sharing actionable member information efficiently in real-time, and providing the connectivity plan members need to improve their overall health," said Sara Izadi, PharmD, Senior Vice President of Pharmacy at Capital Rx. "Our Single-Ledger Model™, coupled with JUDI's capabilities, enables us to partner with Virta on a solution focused on deprescribing and health equity." Virta reports lowering HbA1c for patients by 1.3% on average after one year, and 60% of patients enrolled one year attained an HbA1c below 6.5% without using diabetes medications other than metformin. Moreover, patients experience an average of 12% body weight loss at two years. And like Capital Rx, which saves payers 10% - 30% in the first year, on average, after switching from a traditional PBM model, Virta emphasizes positive financial outcomes, including demonstrating an estimated $503 per engaged member per month gross savings for T2D reversal participants. Three Rx Reverse options are available for plan sponsors to choose from Type 2 Diabetes Reversal: Helps plan members achieve lower blood sugar – often to sub-diabetes levels <6.5 A1c – and clinically significant weight loss alongside safe deprescription of diabetes medication. Provider-Led Weight Loss: Helps plan members without diabetes who are considered overweight (BMI ≥ 25) or obese (BMI ≥ 30) achieve clinically significant weight loss. Type 2 Diabetes Reversal & Provider-Led Weight Loss "The rapidly rising utilization and cost of obesity and diabetes drugs is putting extreme pressure on healthcare payers," said Kevin Kumler, President at Virta Health. "Capital Rx's tech-forward, value-based approach – a needed evolution from the traditional PBM model – aligns both incentives and systems to help payers control drug costs while members get healthier." About Virta Health Virta Health is the leader in type 2 diabetes reversal and is creating a new standard in medical care for people living with type 2 diabetes, prediabetes, or obesity. The company's virtual approach combines personalized nutrition therapy with continuous provider-led support to empower members to eliminate medications, lose weight, and take back their lives. Virta has earned the trust of the nation's largest organizations, including Humana, AutoZone, and Blue Shield of California, delivering industry-leading cost savings of over $6,000 per member per year while putting our fees at risk based on health outcomes. About Capital Rx Capital Rx is a healthcare technology company changing the way prescription drugs are priced and patients are cared for in America. As a Certified B Corp™, Capital Rx is executing its mission through a Single-Ledger Model™, the industry's first ethical framework for drug pricing. The company's cloud-native enterprise pharmacy platform, JUDI®, connects every aspect of the pharmacy ecosystem, servicing over 2.4 million members for Medicare, Medicaid, and commercial plans.

Read More

Health Technology, Healthcare Analytics

AmeriPro Health expands to Kentucky and Indiana with acquisition of AMR's operations

prnewswire | August 07, 2023

AmeriPro Health, a leading provider of patient logistics and last-mile healthcare delivery services, has acquired American Medical Response, Inc.'s (AMR) operations in Lexington and Louisville, Kentucky, and New Albany, Indiana. As a result of the acquisition, AmeriPro Health now provides these three markets, which include UofL Health, University of Louisville Athletics and UK HealthCare, with its customizable suite of patient-centric 911, inter-facility medical transportation, critical care and advanced life support (ALS) services. "We're thrilled to bring AmeriPro's innovative last-mile services to Lexington, Louisville and New Albany," says Suhas Uppalapati, CEO of AmeriPro Health. "AmeriPro is steadfast in our commitment to revolutionize patient logistics. We aim to provide members of these communities - and blue-chip institutional partners such as UK HealthCare and UofL Health, along with other local hospitals, health plans and employers - with unmatched patient health services." This news follows AmeriPro's 2022 acquisition of CareMed, an ambulance service provider in Mississippi and Tennessee, and Ambulance Service, Inc., a longstanding Jacksonville, Florida-based EMS provider, in 2019. Established in 2018 with 10 ambulances in the Metro Atlanta area, AmeriPro Health has rapidly grown to 800+ employees with operations across six states. About AmeriPro Health AmeriPro Health encompasses a diverse range of healthcare companies devoted to optimizing patient logistics and last-mile healthcare delivery. Our extensive portfolio comprises emergency and critical care services, non-emergency medical transportation, patient coordination and personalized home-based care solutions, providing a seamless patient care journey. By covering the complete spectrum of patient care, we ensure enhanced patient outcomes, more efficient healthcare processes and timely, location-appropriate access to care. At AmeriPro Health, we provide an adaptable suite of patient-centric, value-driven services, tailored to meet the needs of communities, health systems, health plans and employers. As a pioneer in last-mile healthcare, our strength lies in our capacity to anticipate future needs, swiftly adapt and deliver on the evolving demands of our clients.

Read More

Digital Healthcare, Healthcare Analytics

Equum Medical Launches the Lighthouse Series™: Inspiring Success Stories in Telehealth and Healthcare Transformation

PRNewswire | July 24, 2023

Evidence is mounting from the experiences of hospitals large and small, urban and rural that telehealth is having a positive effect on staffing, patient safety, clinical services and hospital revenue, Equum Medical reports. The company, a leading provider of innovative telehealth services, has released the Equum Medical Lighthouse Series™. These customer success stories showcase the transformative power of telehealth in addressing key challenges faced by health systems and hospitals worldwide. The Series is intended to highlight real-world examples of how a complete acute care telehealth service using remote physicians, nurses and monitoring technologists supplements current hospital staff, provides specialist expertise and quickly moves patients to the most appropriate sites for care. In today's rapidly evolving healthcare landscape, health systems and hospitals are constantly seeking innovative solutions to enhance efficiency, reduce costs and improve patient outcomes. The Equum Medical Lighthouse Series brings to the forefront some of the most pressing challenges faced by healthcare providers, including ED capacity, ICU mortality and length of stay, physician and nurse burnout, and rural hospital specialist access. Telehealth offers a promising solution by increasing access to care in underserved areas, alleviating the shortage of clinicians and reducing costs to make healthcare more accessible and affordable. Dr. Scurlock, CEO and Founder of Equum Medical, emphasized the importance of sharing these success stories: "We are thrilled to launch the Equum Medical Lighthouse Series. By showcasing real-world examples of how telehealth has successfully addressed critical challenges, we aim to encourage broader adoption of telehealth and the dissemination of information on successful strategies." The series aims to provide healthcare leaders with actionable insights and evidence-based strategies to navigate their own telehealth implementations by demonstrating the tangible benefits that can be achieved by embracing telehealth and leveraging its potential to drive positive change in healthcare delivery. Healthcare providers, administrators and industry professionals can gain a valuable resource for understanding the diverse applications of telehealth and the significant impact it can have on healthcare delivery, patient outcomes and the overall well-being of both patients and providers. "We are going to continue to grow the Lighthouse Series as we get additional results from our engagements," said Karsten Russell-Wood, MBA, MPH, Equum's Chief Marketing Officer. "We want this to be a resource for innovators and evidence of what our model of care can do to ease the pressure on hospitals and health systems in this time of profound change for our industry." Equum Medical is an active member of the American Telemedicine Association and the National Rural Health Association, through which participating hospital systems can access thought leadership and engage with Equum Medical executives to expand telehealth understanding and applications. About Equum Equum Medical is a nationally recognized, tech-enabled clinical services company that provides the people and processes that ensure investments in telehealth technology succeed in transforming inpatient care. Equum's clinical services platform focuses on the acute care population spanning ED, ICU, nursing and sitter solutions.

Read More

Health Technology, Healthcare Analytics

Capital Rx Launches Rx Reverse in Partnership with Virta Health to Combat Type 2 Diabetes and Obesity

PRNewswire | July 18, 2023

Capital Rx, the health technology company changing the way prescription drugs are priced and patients are cared for, and type 2 diabetes (T2D) reversal leader Virta Health have partnered to introduce Rx Reverse. Available to all of Capital Rx's customers, Rx Reverse is a high-touch, provider-led, integrated clinical program designed to help members reverse T2D and fight obesity without costly medications. The problem is clear: 37+ million Americans have been diagnosed with diabetes, and over 90% of them have T2D (including one-third of the population over 65 years old).1 At the same time, the prevalence of obesity is over 40% of the U.S. population2 and is expected to reach nearly 50% by 2030.3 During a June 15, 2023 webinar, Rethinking Obesity Strategies: The Rise of GLP-1 Drugs and Lifestyle Programs for Weight Loss, Virta revealed new survey data highlighting that diabetes and obesity are the #1 and #2 concerns of health plan leaders in 2023 because of rising costs and downstream health impact. The launch of Rx Reverse comes as demand for GLP-1 drugs approved for diabetes and weight loss is rising rapidly, and employers and health plan leaders focus on managing the cost of diabetes and obesity. Rx Reverse combines Capital Rx's tech-enabled pharmacy benefit management (PBM) service model, powered by JUDI®, and Virta's solution – personalized nutrition therapy, physician-led deprescription, remote monitoring, and one-on-one coaching – to help health plans reduce costs and improve members' health. "Leveraging JUDI, our proprietary next-generation claim adjudication platform for Medicare, Medicaid, and commercial plans, we have the ability to seamlessly connect with vendors like Virta, sharing actionable member information efficiently in real-time, and providing the connectivity plan members need to improve their overall health," said Sara Izadi, PharmD, Senior Vice President of Pharmacy at Capital Rx. "Our Single-Ledger Model™, coupled with JUDI's capabilities, enables us to partner with Virta on a solution focused on deprescribing and health equity." Virta reports lowering HbA1c for patients by 1.3% on average after one year, and 60% of patients enrolled one year attained an HbA1c below 6.5% without using diabetes medications other than metformin. Moreover, patients experience an average of 12% body weight loss at two years. And like Capital Rx, which saves payers 10% - 30% in the first year, on average, after switching from a traditional PBM model, Virta emphasizes positive financial outcomes, including demonstrating an estimated $503 per engaged member per month gross savings for T2D reversal participants. Three Rx Reverse options are available for plan sponsors to choose from Type 2 Diabetes Reversal: Helps plan members achieve lower blood sugar – often to sub-diabetes levels <6.5 A1c – and clinically significant weight loss alongside safe deprescription of diabetes medication. Provider-Led Weight Loss: Helps plan members without diabetes who are considered overweight (BMI ≥ 25) or obese (BMI ≥ 30) achieve clinically significant weight loss. Type 2 Diabetes Reversal & Provider-Led Weight Loss "The rapidly rising utilization and cost of obesity and diabetes drugs is putting extreme pressure on healthcare payers," said Kevin Kumler, President at Virta Health. "Capital Rx's tech-forward, value-based approach – a needed evolution from the traditional PBM model – aligns both incentives and systems to help payers control drug costs while members get healthier." About Virta Health Virta Health is the leader in type 2 diabetes reversal and is creating a new standard in medical care for people living with type 2 diabetes, prediabetes, or obesity. The company's virtual approach combines personalized nutrition therapy with continuous provider-led support to empower members to eliminate medications, lose weight, and take back their lives. Virta has earned the trust of the nation's largest organizations, including Humana, AutoZone, and Blue Shield of California, delivering industry-leading cost savings of over $6,000 per member per year while putting our fees at risk based on health outcomes. About Capital Rx Capital Rx is a healthcare technology company changing the way prescription drugs are priced and patients are cared for in America. As a Certified B Corp™, Capital Rx is executing its mission through a Single-Ledger Model™, the industry's first ethical framework for drug pricing. The company's cloud-native enterprise pharmacy platform, JUDI®, connects every aspect of the pharmacy ecosystem, servicing over 2.4 million members for Medicare, Medicaid, and commercial plans.

Read More

More featured news